Insitrex-TZ 562.5 Injection
By Insitrex-TZ
Rx
1 Injection in a Vial

Composition
Ceftriaxone(500mg) + Tazobactum(62.5mg)

Manufacturer - Insinius Pharmaceuticals
Vill. Dera (Kala Amb), Teh. Naraingarh, Distt. Ambala, Haryana – 134203, India

Expires on or after
September, 2025

liver
Insitrex-TZ 562.5 Injection requires caution when used by individuals with severe liver disease. It may be necessary to adjust the dosage of Insitrex-TZ 562.5 Injection in these patients. It is important to consult your doctor before using this medication if you have severe liver disease. However, for patients with mild to moderate liver disease, dose adjustment of Insitrex-TZ 562.5 Injection is typically not necessary.

kidney
Caution is advised regarding the use of Insitrex-TZ 562.5 Injection in patients with kidney disease. It is important to consult your doctor for guidance on its use in such cases.

alcohol
When using Insitrex-TZ 562.5 Injection, it is safe to drink alcohol as there are no harmful side effects. For advice on alcohol consumption during pregnancy, consult your doctor.

driving
When using Insitrex-TZ 562.5 Injection, you may experience decreased alertness, vision changes, drowsiness, and dizziness. Avoid driving if these effects are present.

pregnancy
Insitrex-TZ 562.5 Injection is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.

breastfeeding
Insitrex-TZ 562.5 Injection must be used cautiously during breastfeeding. It is advisable to pause breastfeeding until the mother's treatment is finished and the drug has cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹95
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 18-Nov-2024